Evidence map›Paper›PMID 27746914›Full record

ReviewJournal of materials chemistry. B2016

Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering.

B Lucendo-Villarin, H Rashidi, K Cameron, D C Hay

Abstract readReview
In one paragraph

Review in Journal of materials chemistry. B, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Developing defined substrates for stem cell culture and differentiation.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2018
    Review
  10. Liver cell therapy: is this the end of the beginning?Cellular and molecular life sciences : CMLS · 2018
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

B Lucendo-VillarinMedical Research Council Centre for Regenerative Medicine , University of Edinburgh , 5 Little France Drive , Edinburgh , EH16 4UU , Scotland , UK . Email: davehay@talktalk.net ; Tel: +44(0)1316519500.
H RashidiMedical Research Council Centre for Regenerative Medicine , University of Edinburgh , 5 Little France Drive , Edinburgh , EH16 4UU , Scotland , UK . Email: davehay@talktalk.net ; Tel: +44(0)1316519500.
K CameronMedical Research Council Centre for Regenerative Medicine , University of Edinburgh , 5 Little France Drive , Edinburgh , EH16 4UU , Scotland , UK . Email: davehay@talktalk.net ; Tel: +44(0)1316519500.
D C HayMedical Research Council Centre for Regenerative Medicine , University of Edinburgh , 5 Little France Drive , Edinburgh , EH16 4UU , Scotland , UK . Email: davehay@talktalk.net ; Tel: +44(0)1316519500.

Funding

Medical Research Council MR/K017047/1Medical Research Council MR/K026666/1Medical Research Council MR/L010011/1Medical Research Council MR/L022974/1
6 · The paper itself

Abstract

Pluripotent stem cell derived liver cells (hepatocytes) represent a promising alternative to primary tissue for biological and clinical applications. To date, most hepatocyte maintenance and differentiation systems have relied upon the use of animal derived components. This serves as a significant barrier to large scale production and application of stem cell derived hepatocytes. Recently, the use of defined biologics has overcome those limitations in two-dimensional monolayer culture. In order to improve the cell phenotype further, three-dimensional culture systems have been employed to better mimic the

Identifiers

PMID27746914
PMCPMC5024673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.